The B-cell antigen receptor of IgE-switched plasma cells regulates memory IgE responses - 05/09/20
Abstract |
Background |
Allergic inflammation is driven by IgE-producing plasma cells (PCs), which are required for IgE-mediated activation of mast cells and basophils. Repeated antigen encounter elicits a memory IgE response with elevated serum IgE titers and accumulation of IgE-producing PCs. However, the cellular compartment and molecular signals that underlie the immunologic memory of IgE responses remain unclear.
Objective |
With this study we aimed at clarifying whether inactivation of the cytoplasmic immunoglobulin tail tyrosine (ITT) motif in transmembrane IgE (mIgE) impairs the memory IgE response in mice.
Methods |
We generated mice with an inactivated mIgE-ITT motif and analyzed serum IgE levels as well as the generation of IgE-producing germinal center B cells and PCs subsequent to primary and secondary infection with helminths. In vitro cultures were used to study the mIgE-ITT–controlled expression of mIgE on the surface of PCs. Systemic mast cell activation was determined by serum Mcpt1 ELISA in response to ovalbumin challenge.
Results |
mIgE-ITT–mutant mice showed an impaired memory IgE response subsequent to helminth infection. Furthermore, sensitization and challenge of mIgE-ITT–mutant mice with ovalbumin resulted in diminished serum IgE titers and reduced mast cell activation. The mIgE-ITT motif was required for optimal cell surface expression of mIgE B-cell antigen receptors but not for intracellular IgE expression in PCs.
Conclusion |
These results indicate that the mIgE B-cell antigen receptor plays a critical role in establishing or maintaining the population of IgE-producing PCs during memory IgE responses.
Il testo completo di questo articolo è disponibile in PDF.Graphical abstract |
Key words : Allergy, helminths, IgE, plasma cells, B-cell receptor
Abbreviations used : BCR, CSR, CY, EMPD, GC, ITT, mIgE, mIgG1, MLN, mIgE-YF, OVA, PC, PE
Mappa
Supported by the Deutsche Forschungsgemeinschaft (grant TRR130_TP08 [to N.E. and J.W.] and grant TRR130_TP20 [to D.V.]). |
|
Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interests. |
Vol 146 - N° 3
P. 642 - Settembre 2020 Ritorno al numeroBenvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?